How much text recycling is okay?

Are there a limited number of ways to describe the the background and methods of an experiment? Once something has been written well, and vetted by editors, is it a waste of time to rewrite it ? And if text has been reused, how should that be indicated — if at all? These are questions … Continue reading How much text recycling is okay?

Historian returns prize for high-profile book with 70+ corrections

A historian based at Columbia University has returned a 2014 prize after criticisms prompted him to issue more than 70 corrections to his prominent book about North Korea. Charles Armstrong told Retraction Watch he returned the 2014 John K. Fairbank Prize he received for “Tyranny of the Weak” due to “numerous citation errors.” The book has … Continue reading Historian returns prize for high-profile book with 70+ corrections

Weekend reads: Why a vice-chancellor uses Impact Factors; plagiarizing principals; time to publish less?

The week at Retraction Watch featured the tale of a scientist whose explanations for misconduct kept changing, and revelations in a big legal case involving Duke University. Here’s what was happening elsewhere:

Weekend reads: Death penalty for scientific fraud?; Why criticism is good; Cash for publishing

The week at Retraction Watch featured revelations about a case of misconduct at the University of Colorado Denver, and the case of a do-over that led to a retraction. Here’s what was happening elsewhere:

No new math: Journal pulls math paper with “already known” results

A mathematics journal has withdrawn a paper after discovering that the results were not new. The paper, published online in March in Communications in Algebra, explored the properties of group rings, a discipline of algebra. According to editor-in-chief of the journal, Jason Bell, author Francis E. A. Johnson, a professor of mathematics at the University … Continue reading No new math: Journal pulls math paper with “already known” results

Springer purge of fake reviews takes down 10+ more neuroscience papers

Back in April, Springer retracted a record number 107 papers from Tumor Biology after uncovering evidence they were subject to fake peer reviews. But it appears that the Tumor Biology sweep was only part of the story. During the Tumor Biology investigation, Springer found evidence that the “peer review process was compromised” in a dozen papers … Continue reading Springer purge of fake reviews takes down 10+ more neuroscience papers

Weekend reads: A demand for a CRISPR paper retraction; a weak data-sharing policy; can we trust journals?

The week at Retraction Watch featured a study suggesting that 2% of studies in eight medical journals contained suspect data, and the announcement of a retraction on a professor’s blog. Here’s what was happening elsewhere:

Journal won’t look at allegations about papers more than six years old, nor comment on those from “public websites”

After a paper is published, how long should a journal consider allegations of misconduct? For one journal, that answer is: Six years. We see plenty of journals that retract papers at least 10 years old over concerns regarding misconduct, but in a recent editorial, Molecular and Cellular Biology announced it would pursue allegations made within … Continue reading Journal won’t look at allegations about papers more than six years old, nor comment on those from “public websites”

A retraction gets retracted — but the first author’s contract is still terminated

After issuing a retraction notice May 30 for a biomedical engineering paper, the journal has since pulled the notice, citing “a potential problem.” After doing some digging, we’ve learned more about the “potential problem.” Apparently, the retraction was requested by Nanyang Technological University (NTU) in Singapore. NTU has been investigating the first author for months, after it received … Continue reading A retraction gets retracted — but the first author’s contract is still terminated

Two in 100 clinical trials in eight major journals likely contain inaccurate data: Study

A sweeping analysis of more than 5,000 papers in eight leading medical journals has found compelling evidence of suspect data in roughly 2% of randomized controlled clinical trials in those journals. Although the analysis, by John Carlisle, an anesthetist in the United Kingdom, could not determine whether the concerning data were tainted by misconduct or … Continue reading Two in 100 clinical trials in eight major journals likely contain inaccurate data: Study